Why is WHO failing women with falciparum malaria in the first trimester of pregnancy?

Rose McGready; François Nosten; Karen I. Barnes; Olugbenga Ayodeji Mokuolu; Sir Nicholas White

doi:10.1016/s0140-6736(20)30161-6

Related publications

Article2009

The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria

Rose McGready, Kasia Stepniewska, Niklas Lindegårdh, Elizabeth A. Ashley, Yar La, Pratap Singhasivanon, Sir Nicholas White, François Nosten

European Journal of Clinical Pharmacology

Article2003

The pharmacokinetics of atovaquone and proguanil in pregnant women with acute falciparum malaria

Rose McGready, Kasia Stepniewska, Michael D. Edstein, T. Cho, G. Gilveray, S. Looareesuwan, Sir Nicholas White, François Nosten

European Journal of Clinical Pharmacology

Article2006

The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria

Rose McGready, Kasia Stepniewska, Niklas Lindegårdh, Elizabeth A. Ashley, Yar La, Pratap Singhasivanon, Sir Nicholas White, François Nosten

European Journal of Clinical Pharmacology

Article2021

Falciparum but not vivax malaria increases the risk of hypertensive disorders of pregnancy in women followed prospectively from the first trimester

Whitney E. Harrington, Kerryn A. Moore, Aung Myat Min, Mary Ellen Gilder, Nay Win Tun, Moo Kho Paw, Jacher Wiladphaingern, Stéphane Proux, Kesinee Chotivanich, Marcus J. Rijken, Sir Nicholas White, François Nosten, Rose McGready

BMC Medicine

Article2006

Pharmacokinetics of dihydroartemisinin following oral artesunate treatment of pregnant women with acute uncomplicated falciparum malaria

Rose McGready, Kasia Stepniewska, Stephen A. Ward, T. Cho, G. Gilveray, S. Looareesuwan, Sir Nicholas White, François Nosten

European Journal of Clinical Pharmacology

Why is WHO failing women with falciparum malaria in the first trimester of pregnancy?

Abstract

Discussion(0)

Related publications

The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria

The pharmacokinetics of atovaquone and proguanil in pregnant women with acute falciparum malaria

The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria

Falciparum but not vivax malaria increases the risk of hypertensive disorders of pregnancy in women followed prospectively from the first trimester

Pharmacokinetics of dihydroartemisinin following oral artesunate treatment of pregnant women with acute uncomplicated falciparum malaria